Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

JW Blasetto, EA Stein, WV Brown, R Chitra… - The American journal of …, 2003 - Elsevier
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …

[PDF][PDF] Efficacy of Rosuvastatin Compared with Other Statins at Selected Starting Doses in Hypercholesterolemic Patients and in Special Population Groups

JW Blasetto, EA Stein, WV Brown, R Chitra, A Raza - Am J Cardiol, 2003 - academia.edu
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

JW Blasetto, EA Stein, WV Brown… - … American journal of …, 2003 - pubmed.ncbi.nlm.nih.gov
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …

[引用][C] Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. Discussions

JW BLASETTO, EA STEIN, WV BROWN… - … American journal of …, 2003 - pascal-francis.inist.fr
Efficacy of rosuvastatin compared with other statins at selected starting doses in
hypercholesterolemic patients and in special population groups. Discussions CNRS Inist …

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.

JW Blasetto, EA Stein, WV Brown, R Chitra… - The American Journal …, 2003 - europepmc.org
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

JW Blasetto, EA Stein, WV Brown, R Chitra… - The American Journal of …, 2003 - infona.pl
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …

[引用][C] Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemia patients and in special population groups

J BLASETTO - Am J Cardiol, 2003 - cir.nii.ac.jp
Efficacy of rosuvastatin compared with other statins at selected starting doses in
hypercholesterolemia patients and in special population groups | CiNii Research CiNii 国立 …

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

JW Blasetto, EA Stein, WV Brown, R Chitra… - American Journal of …, 2003 - ajconline.org
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

JW Blasetto, EA Stein, WV Brown, R Chitra… - The American Journal of …, 2003 - elibrary.ru
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …

[PDF][PDF] Efficacy of Rosuvastatin Compared with Other Statins at Selected Starting Doses in Hypercholesterolemic Patients and in Special Population Groups

JW Blasetto, EA Stein, WV Brown, R Chitra, A Raza - Am J Cardiol, 2003 - academia.edu
A total of 5 randomized, double-blind trials in patients with hypercholesterolemia were
prospectively designed to allow pooling of plasma lipid data after 12 weeks of treatment. The …